224 related articles for article (PubMed ID: 21233844)
1. Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action.
Lorente M; Torres S; Salazar M; Carracedo A; Hernández-Tiedra S; Rodríguez-Fornés F; García-Taboada E; Meléndez B; Mollejo M; Campos-Martín Y; Lakatosh SA; Barcia J; Guzmán M; Velasco G
Cell Death Differ; 2011 Jun; 18(6):959-73. PubMed ID: 21233844
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of ALK by the growth factor midkine renders glioma cells resistant to autophagy-mediated cell death.
Lorente M; Torres S; Salazar M; Carracedo A; Hernández-Tiedra S; Rodríguez-Fornés F; García-Taboada E; Meléndez B; Mollejo M; Campos-Martín Y; Barcia JA; Guzmán M; Velasco G
Autophagy; 2011 Sep; 7(9):1071-3. PubMed ID: 21593591
[TBL] [Abstract][Full Text] [Related]
3. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
López-Valero I; Dávila D; González-Martínez J; Salvador-Tormo N; Lorente M; Saiz-Ladera C; Torres S; Gabicagogeascoa E; Hernández-Tiedra S; García-Taboada E; Mendiburu-Eliçabe M; Rodríguez-Fornés F; Sánchez-Domínguez R; Segovia JC; Sánchez-Gómez P; Matheu A; Sepúlveda JM; Velasco G
Theranostics; 2020; 10(11):5120-5136. PubMed ID: 32308772
[TBL] [Abstract][Full Text] [Related]
4. Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis.
Lorente M; Carracedo A; Torres S; Natali F; Egia A; Hernández-Tiedra S; Salazar M; Blázquez C; Guzmán M; Velasco G
Glia; 2009 Oct; 57(13):1374-85. PubMed ID: 19229996
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.
Salazar M; Carracedo A; Salanueva IJ; Hernández-Tiedra S; Lorente M; Egia A; Vázquez P; Blázquez C; Torres S; García S; Nowak J; Fimia GM; Piacentini M; Cecconi F; Pandolfi PP; González-Feria L; Iovanna JL; Guzmán M; Boya P; Velasco G
J Clin Invest; 2009 May; 119(5):1359-72. PubMed ID: 19425170
[TBL] [Abstract][Full Text] [Related]
6. A combined preclinical therapy of cannabinoids and temozolomide against glioma.
Torres S; Lorente M; Rodríguez-Fornés F; Hernández-Tiedra S; Salazar M; García-Taboada E; Barcia J; Guzmán M; Velasco G
Mol Cancer Ther; 2011 Jan; 10(1):90-103. PubMed ID: 21220494
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.
Blázquez C; Salazar M; Carracedo A; Lorente M; Egia A; González-Feria L; Haro A; Velasco G; Guzmán M
Cancer Res; 2008 Mar; 68(6):1945-52. PubMed ID: 18339876
[TBL] [Abstract][Full Text] [Related]
8. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.
López-Valero I; Torres S; Salazar-Roa M; García-Taboada E; Hernández-Tiedra S; Guzmán M; Sepúlveda JM; Velasco G; Lorente M
Biochem Pharmacol; 2018 Nov; 157():275-284. PubMed ID: 30125556
[TBL] [Abstract][Full Text] [Related]
9. The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action.
Salazar M; Lorente M; García-Taboada E; Hernández-Tiedra S; Davila D; Francis SE; Guzmán M; Kiss-Toth E; Velasco G
Biochim Biophys Acta; 2013 Oct; 1831(10):1573-8. PubMed ID: 23567453
[TBL] [Abstract][Full Text] [Related]
10. Ethanol activates midkine and anaplastic lymphoma kinase signaling in neuroblastoma cells and in the brain.
He D; Chen H; Muramatsu H; Lasek AW
J Neurochem; 2015 Nov; 135(3):508-21. PubMed ID: 26206265
[TBL] [Abstract][Full Text] [Related]
11. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G
Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional factor specificity protein 1 (SP1) promotes the proliferation of glioma cells by up-regulating midkine (MDK).
Luo J; Wang X; Xia Z; Yang L; Ding Z; Chen S; Lai B; Zhang N
Mol Biol Cell; 2015 Feb; 26(3):430-9. PubMed ID: 25428991
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?
Blázquez C; Carracedo A; Salazar M; Lorente M; Egia A; González-Feria L; Haro A; Velasco G; Guzmán M
Neuropharmacology; 2008 Jan; 54(1):235-43. PubMed ID: 17675107
[TBL] [Abstract][Full Text] [Related]
14. Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition.
Reiff T; Huber L; Kramer M; Delattre O; Janoueix-Lerosey I; Rohrer H
Development; 2011 Nov; 138(21):4699-708. PubMed ID: 21989914
[TBL] [Abstract][Full Text] [Related]
15. Expression of the pleiotrophin-midkine axis in a sheep tooth socket model of bone healing.
Nobakht S; Milne TJ; Duncan WJ; Ram A; Tkatchenko T; Dong Z; Coates DE
J Periodontal Res; 2023 Feb; 58(1):109-121. PubMed ID: 36411509
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids and gliomas.
Velasco G; Carracedo A; Blázquez C; Lorente M; Aguado T; Haro A; Sánchez C; Galve-Roperh I; Guzmán M
Mol Neurobiol; 2007 Aug; 36(1):60-7. PubMed ID: 17952650
[TBL] [Abstract][Full Text] [Related]
17. The Drosophila midkine/pleiotrophin homologues Miple1 and Miple2 affect adult lifespan but are dispensable for alk signaling during embryonic gut formation.
Hugosson F; Sjögren C; Birve A; Hedlund L; Eriksson T; Palmer RH
PLoS One; 2014; 9(11):e112250. PubMed ID: 25380037
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.
Blázquez C; González-Feria L; Alvarez L; Haro A; Casanova ML; Guzmán M
Cancer Res; 2004 Aug; 64(16):5617-23. PubMed ID: 15313899
[TBL] [Abstract][Full Text] [Related]
19. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.
Werner MT; Zhao C; Zhang Q; Wasik MA
Blood; 2017 Feb; 129(7):823-831. PubMed ID: 27879258
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.
Katayama R; Sakashita T; Yanagitani N; Ninomiya H; Horiike A; Friboulet L; Gainor JF; Motoi N; Dobashi A; Sakata S; Tambo Y; Kitazono S; Sato S; Koike S; John Iafrate A; Mino-Kenudson M; Ishikawa Y; Shaw AT; Engelman JA; Takeuchi K; Nishio M; Fujita N
EBioMedicine; 2016 Jan; 3():54-66. PubMed ID: 26870817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
